Endpoints for Assessing Drug Activity in Clinical Trials. Pazdur, R. The Oncologist, 13(Supplement 2):19–21, April, 2008.
Endpoints for Assessing Drug Activity in Clinical Trials [link]Paper  doi  bibtex   
@article{pazdur_endpoints_2008-1,
	title = {Endpoints for {Assessing} {Drug} {Activity} in {Clinical} {Trials}},
	volume = {13},
	issn = {1083-7159, 1549-490X},
	url = {http://theoncologist.alphamedpress.org/cgi/doi/10.1634/theoncologist.13-S2-19},
	doi = {10.1634/theoncologist.13-S2-19},
	language = {en},
	number = {Supplement 2},
	urldate = {2019-05-02},
	journal = {The Oncologist},
	author = {Pazdur, R.},
	month = apr,
	year = {2008},
	pages = {19--21},
	file = {Pazdur - 2008 - Endpoints for Assessing Drug Activity in Clinical .pdf:/Users/neil.hawkins/Zotero/storage/U8JZZ443/Pazdur - 2008 - Endpoints for Assessing Drug Activity in Clinical .pdf:application/pdf},
}

Downloads: 0